GLA-funded researchers—who were the first to prove the existence of the previously disputed chronic Lyme condition—have decoded the Lyme genome, discovered how the disease can survive antibiotic therapy, and now understand far more about what makes the Lyme bacterium different than any other type of infection. Learn more about our research.
GLA has forged significant partnerships with the academic community who support research. Most notably, the organization partnered in 2007 with the Lyme Disease Association to fund and create the first research center for the study of persistent Lyme at Columbia University Medical Center in New York City.
For the past decade, GLA has funded innovative and promising research at top-tier universities across the United States, including Johns Hopkins University, Washington University in St Louis, Texas A&M, Northeastern University, University of Missouri, University of California San Francisco, University of Pennsylvania and Stony Brook University.
GLA announced a partnership with Ionica Sciences in October 2017 to develop an accurate Lyme disease diagnostic test.
GLA has identified and funded groundbreaking research in the areas of diagnostics, therapeutics, and basic understanding of the Lyme bacterium:
You are not in this journey alone! This program connects people who are affected by Lyme disease and/or other tick-borne illness with others who have been through it.
Patients can play an important role in advancing the understanding of Lyme and other tick-borne illnesses and aid in the discovery of new or improved treatments by participating in a clinical trial.
Connect with a doctor who understands Lyme disease and how to treat it. We will connect you with a Lyme disease specialist in your area.